The Second Round

Validation of the data management system is typically done in two rounds. First, correctly completed data forms are entered to ensure that the system is not flagging any good data. In the second round, completed data forms with intentional data errors are entered. All errors must be identified by the system. 

Fig. 20.5 Schematic representation of the second round of differential display studies undertaken to identify transcripts containing AREs in the 3 -UTR that are regulated by chronic lithium and VPA.

In the second round of amplification, a PCR is performed using the products of the two individual PCRs from the first amplification as templates in the presence of only primers 1 and 4. The complementary ends of the two internal standard halves anneal to each other, priming the production of a complete double-stranded internal standard. This product is then further amplified by repeated (PCR) amplification with primers 1 and 4. 

For QM-MSP, first the promoter regions of several genes will be amplified using primes that correspond to the CG-free regions (45). Then, 1 pL of the diluted PCR product (30-50 times) is used as the template in real-time QM-MSP to quantify the methylated and unmethylated template in separate reactions using methylation- or nonmethylation-specific primers. The benefits of this method are that (1) the instability of bisulfite-modified DNA is remedied using an initial round of PCR (2) nonspecific products that compromise the accuracy of SYBR green-based real-time PCR are eliminated in the second-round PCR (3) the likelihood of the development of primer dimers is minimized as the first-round PCR product is diluted 50 times and a minimal amount of MSP primers is used in the second-round PCR (4) the amount of the precious DNA used in this approach is substantially less than in the other methods. 

During the second round of testing, it was possible to deploy the sensor on the REMUS. Figure 6.13 is a photograph of the system while operational in the marine environment during the test. While no positive indications of TNT were observed during the test, the sensor was successfully operated on the REMUS in the marine environment. Lessons learned during this deployment led to development of the SeaPup sensor, which was constructed and tested in early 2003. 

Figure 10.1 Home pregnancy testing devices, like the one seen here, utilize biotechnology techniques. This test uses paired monoclonal antibodies and colored beads to indicate increased human gonadotropin in urine. The second round well is a control, indicating the device is working properly by trapping a common urine protein.

Fig. 16.1. Progress of two rounds of Chk1 targeted libraries. Cpd-1 is the original HTS hit with a broad kinase inhibition profile and based on which the first round library was designed and synthesized. 1808-1 is the best hit from the first round targeted library with improved kinase selectivity profile, based on which the second round library was designed and synthesized. 1819-1 is the best lead with improved potency, kinase selectivity, and solubility. Co-crystal structures of Chkl kinase domain and corresponding lead compounds were solved and extensively utilized in structure-based singleton and library designs. For details of the X-ray co-Crystal structures, please refer to the publications from Ming and et al (4a) and Foloppe and et al for details (4b).

Fig. 16.10. Objectives of the second round targeted library. The main goal is to further expand the SAR knowledge around the right-hand side of 1808-1 with the aim to improve potency while retaining kinase selectivity. A same combinatorial synthesis protocol (LJ0194) was used and a 2x88 plate format was planned before the design of the library.

Top hits from the second round library. One compound 1819-1 (0.5 nM) shows significant improvement over tif d 1808-1 (300 nM) in terms of Chk1 inhibition results. More data show (see Fig. 16.1) that it is even more potent th th initial hit Cpd-1 (5 nM) while having a much improved kinase selectivity profile and better solubility. 

Simulated autoradiographs of the E. coli chromosome after one or more replications in the presence of [3H]thymidine. After one round of replication, the autoradiograph shows a circular structure that is uniformly labeled. The second round of replication begins with the formation of a replication eye. One branch in the replication eye is twice as strongly labeled as the remainder of the chromosome, indicating that this branch contains two labeled strands. This structure is consistent with semiconservative replication for the E. coli chromosome. 

For the second round of MACS enrichment, the above protocol can be scaled down... 

Once a new set of positions and widths were determined, the set of linear equations was solved a second time. The search was repeated and the linear equations solved again. No substantial changes were found in either the intensities or positions of reflections after the second round of fitting the non-linear parameters. 

This is now ready for the second round of biopanning, so that d 3 now becomes d 2 again (see Note 5). 

Because the periodic orbits are highly unstable in the present example (i.e., the slightest distortion destroys the periodicity and leads to dissociation) the trapped trajectories recur only once after returning to their origin they start again, with a new set of initial conditions, and most probably will dissociate in the second round. 

Bone marrow cell first time stimulation medium 77% (v/v) DMEM, 15% (v/v) heat inactivated FBS, 5% (v/v) WEHI-3B conditioned medium, penicillin-streptomycin, 1.0 m g/mL ciprofloxacin, 200 mM L-glutamine, 6 ng/mL recombinant murine IL-3 (Peprotech, Cat 213-13), 10 ng/mL recombinant murine IL-6 (Peprotech, Cat 216-lb), and 50-100 ng/mL recombinant murine stem cell factor (SCF Peprotech, Cat 250-03). The total volume is 10 mL for each sample. For the second round stimulating medium, the volume is 4 mL for each sample. 

Centrifuge for 10 min at 4000g to remove the gel fragments and take out the supernatant. Perform the second round of elution... 

---